Neuropace (NPCE) Earnings Date & Reports

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NPCE is expected to report earnings to rise 35.22% to -24 cents per share on May 08

Q1'25

Est.

$-0.24

Q4'24

Beat

by $0.07

Q3'24

Beat

by $0.08

Q2'24

Beat

by $0.04

Q1'24

Est.

$-0.32

The last earnings report on March 04 showed earnings per share of -18 cents, beating the estimate of -25 cents. With 103.05K shares outstanding, the current market capitalization sits at 385.20M.

View a ticker or compare two or three

Compare

NPCE